News
August 5, 2022
Pharmtech Focus: Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics
// Read More
July 29, 2022
Labiotech.eu: Biotech startup Novasenta raises $40M to advance novel cancer therapeutics
// Read More
July 29, 2022
Endpoints Exclusive: UPMC launches another biotech, rooted in the tumor microenvironment
// Read More
August 31, 2021
Next Pittsburgh: UPMC Enterprises invests $20 million in startup changing the way we fight cancer
// Read More
August 27, 2021
Pittsburgh Business Times: UPMC launches cancer drug development firm Novasenta
// Read More
August 24, 2021
Pittsburgh Post-Gazette: UPMC launches immunotherapies startup in South Oakland
// Read More
August 23, 2021
India Education Diary: UPMC Launches Novasenta to Develop Targeted Immunotherapy Drugs for Cancer
// Read More